Edition:
India

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

23.75USD
1:32am IST
Change (% chg)

$0.03 (+0.13%)
Prev Close
$23.72
Open
$23.73
Day's High
$23.77
Day's Low
$23.57
Volume
2,013,836
Avg. Vol
2,772,661
52-wk High
$24.78
52-wk Low
$15.68

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP),... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $32,276.83
Shares Outstanding(Mil.): 1,360.74
Dividend: --
Yield (%): --

Financials

BRIEF-EndoChoice holdings agreement with Boston Scientific provides termination fee of $7.95 million under certain circumstances

* Agreement with Boston Scientific provides termination fee of $7.95 million under certain circumstances Source text for Eikon: Further company coverage:

27 Sep 2016

BRIEF-Boston Scientific to acquire EndoChoice for $8.00/share

* To evaluate strategic options with respect to FUSE colonoscope, and expects to provide further clarity at/around time of deal closing

27 Sep 2016

BRIEF-Paulson & Co raises share stake in Valeant, Facebook - SEC filing

* Ups share stake in Valeant Pharmaceuticals International Inc by 43.6 pct to 19.1 mln shares - SEC filing

16 Aug 2016

BRIEF-Boston Scientific gets FDA approval for Emblem MRI system

* FDA approval for magnetic resonance (MR) conditional labeling for all previously implanted Emblem S-ICD systems Source text for Eikon: Further company coverage:

09 Aug 2016

Boston Scientific's sales beat on demand for heart devices

Boston Scientific Corp reported better-than-expected quarterly sales as it sold more of its heart devices and revenue from its troubled cardiac rhythm management business increased.

28 Jul 2016

UPDATE 1-Boston Scientific's sales beat on demand for heart devices

July 28 Boston Scientific Corp reported better-than-expected quarterly sales as it sold more of its heart devices and revenue from its troubled cardiac rhythm management business increased.

28 Jul 2016

Boston Scientific reports higher sales on demand for heart devices

July 28 Medical device maker Boston Scientific Corp reported a 15.4 percent rise in quarterly sales as it sold more of its cardiac devices.

28 Jul 2016

BRIEF-Boston Scientific announces acquisition of Cosman Medical

* Sees Cosman Medical team and products will become part of Boston Scientific neuromodulation business

27 Jul 2016

BRIEF-Boston Scientific elects Yoshiaki Fujimori to board

* Boston Scientific elects Yoshiaki Fujimori to board of directors Source text for Eikon: Further company coverage:

13 Jul 2016

BRIEF-Boston Scientific says board increased number of directors from ten to eleven

* Board increased the number of directors comprising the board from ten to eleven - sec filing Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

13 Jul 2016

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $42.29 -0.04
St. Jude Medical, Inc. (STJ.N) $79.73 +0.13
Medtronic PLC (MDT.N) $86.74 +0.07

Earnings vs. Estimates